Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 107Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Lyrica

02 1Lyrica EH

03 2Lyrica Eh

04 1Lyrica GEP

05 1Lyrica GIP

06 1Lyrica IH

07 2Lyrica Ih

08 4Total Lyrica

PharmaCompass

01

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 3,321

2018 Revenue in Millions : 4,970

Growth (%) : -33

blank

02

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 255

2019 Revenue in Millions : 273

Growth (%) : -7

blank

03

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 47

2020 Revenue in Millions : 245

Growth (%) : -79

blank

04

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 8

2021 Revenue in Millions : 47

Growth (%) : -82

blank

05

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 624

2021 Revenue in Millions : 729

Growth (%) : -14

blank

06

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 557

2022 Revenue in Millions : 624

Growth (%) : -11

blank

07

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 253

2016 Revenue in Millions : 233

Growth (%) : 9

blank

08

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 248

2017 Revenue in Millions : 238

Growth (%) : 5%

blank

09

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 268

2018 Revenue in Millions : 257

Growth (%) : 4

blank

10

Brand Name : Lyrica

Pregabalin

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Lyrica

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Pregabalin

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : 12.50%

2013 Revenue in Millions :

Growth (%) :

blank